1. Home
  2. RANI vs WVVI Comparison

RANI vs WVVI Comparison

Compare RANI & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RANI
  • WVVI
  • Stock Information
  • Founded
  • RANI 2012
  • WVVI 1983
  • Country
  • RANI United States
  • WVVI United States
  • Employees
  • RANI N/A
  • WVVI N/A
  • Industry
  • RANI Medicinal Chemicals and Botanical Products
  • WVVI Beverages (Production/Distribution)
  • Sector
  • RANI Health Care
  • WVVI Consumer Staples
  • Exchange
  • RANI Nasdaq
  • WVVI Nasdaq
  • Market Cap
  • RANI 23.2M
  • WVVI 20.4M
  • IPO Year
  • RANI 2021
  • WVVI N/A
  • Fundamental
  • Price
  • RANI $0.47
  • WVVI $4.21
  • Analyst Decision
  • RANI Strong Buy
  • WVVI
  • Analyst Count
  • RANI 4
  • WVVI 0
  • Target Price
  • RANI $7.75
  • WVVI N/A
  • AVG Volume (30 Days)
  • RANI 413.1K
  • WVVI 5.5K
  • Earning Date
  • RANI 11-13-2025
  • WVVI 11-11-2025
  • Dividend Yield
  • RANI N/A
  • WVVI N/A
  • EPS Growth
  • RANI N/A
  • WVVI N/A
  • EPS
  • RANI N/A
  • WVVI N/A
  • Revenue
  • RANI $1,200,000.00
  • WVVI $38,384,350.00
  • Revenue This Year
  • RANI N/A
  • WVVI N/A
  • Revenue Next Year
  • RANI N/A
  • WVVI N/A
  • P/E Ratio
  • RANI N/A
  • WVVI N/A
  • Revenue Growth
  • RANI N/A
  • WVVI N/A
  • 52 Week Low
  • RANI $0.39
  • WVVI $3.17
  • 52 Week High
  • RANI $3.75
  • WVVI $7.18
  • Technical
  • Relative Strength Index (RSI)
  • RANI 41.49
  • WVVI 39.29
  • Support Level
  • RANI $0.47
  • WVVI $4.80
  • Resistance Level
  • RANI $0.51
  • WVVI $5.10
  • Average True Range (ATR)
  • RANI 0.04
  • WVVI 0.24
  • MACD
  • RANI -0.00
  • WVVI -0.01
  • Stochastic Oscillator
  • RANI 21.26
  • WVVI 0.00

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

About WVVI Willamette Valley Vineyards Inc.

Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.

Share on Social Networks: